Discover the future of life sciences in our essential session on the evolving world of IP and its interplay with technological advancements. We’ll cover AI’s impact on pharmaceuticals, future inventions, and the scenarios reshaping IP rights, underscoring their significance on the legal and economic aspects of the industry. Points of discussion will include:

• Examining how artificial intelligence is transforming drug discovery and development
• Discussing the integration of AI in identifying novel molecules and their medical applications, alongside the legal and technical nuances of IP ownership and invention enablement

• Understanding the prediction of patent grant likelihood, the assessment of uniqueness, disruptiveness, and the economic impact on the valuation of entities owning such patents
• Considering the implications for litigation risk and the strategic management of IP portfolios

• Discussing the challenges and opportunities in patent application drafting enhanced by AI, and the evolving criteria for patentability, especially in terms of inventive step and novelty

• Analyzing strategies to secure high-value patents at an early stage and the acceleration of patent processes
• Evaluating the implications for startups and established companies in gaining a competitive edge in the market